MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
AKTS — Aktis Oncology, Inc. Common stock
NasdaqAktis Oncology, Inc. Common stock
$18.52
-0.95(-4.88%)
- O
- 19.41
- H
- 20.08
- L
- 18.31
- V
- 292.22K
⏱️ End-of-day dataAs of Oct 1, 2026
AKTS — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,024.00 | 2,024.00 | 2,024.00 |
| Cash And Cash Equivalents | $37.16M | $37.78M | $18.03M | $37.16M | $22.46M | $24.45M |
| Other Short Term Investments | $16.69M | $18.90M | $65.97M | $26.00M | $87.77M | N/A |
| Other Current Assets | $5.46M | $3.52M | $3.20M | $3.69M | $3.00M | $2.99M |
| Total Current Assets | $54.39M | $23.03M | $24.94M | $30.09M | $31.54M | $36.77M |
| Properties | $25.15M | $24.80M | $24.22M | $21.85M | $20.74M | $8.01M |
| Machinery Furniture Equipment | 979,000.00 | 817,000.00 | 802,000.00 | 754,000.00 | 736,000.00 | 2,000.00 |
| Construction In Progress | $3.07M | $7.01M | $3.96M | $1.33M | 534,000.00 | N/A |
| Leases | $5.11M | 167,000.00 | 167,000.00 | 167,000.00 | 167,000.00 | N/A |
| Accumulated Depreciation | $-6.20M | $-5.54M | $-4.85M | $-3.23M | $-2.79M | -645,000.00 |
| Other Non Current Assets | $4.75M | $7.33M | $5.32M | $4.46M | $2.29M | 71,000.00 |
| Total Non Current Assets | $32.86M | $34.58M | $29.61M | $25.33M | $21.68M | $32.97M |
| Total Assets | $57.68M | $26.49M | $27.90M | $32.62M | $33.71M | $69.74M |
| Accounts Payable | $1.23M | $1.74M | $2.36M | $1.92M | 702,000.00 | $4.00M |
| Accrued Expenses | $5.05M | $4.96M | $4.28M | $3.25M | $4.23M | $12.35M |
| Short Term Debt | $1.43M | $1.31M | $1.37M | $1.30M | $1.49M | $10.51M |
| Deferred Revenue | $18.96M | $18.66M | $16.08M | $9.28M | $8.73M | 131,000.00 |
| Pensions | $1.25M | $4.56M | $2.82M | $3.08M | $1.86M | N/A |
| Total Current Liabilities | $27.91M | $31.24M | $26.91M | $18.82M | $17.01M | $84.37M |
| Long Term Debt | $10.15M | $10.23M | $10.50M | $10.71M | $10.92M | $42.35M |
| Total Non Current Liabilities | $42.78M | $37.98M | $38.45M | $39.52M | $39.69M | $42.47M |
| Total Liabilities | $70.69M | $41.10M | $41.14M | $41.40M | $41.39M | $12.68M |
| Common Stock | 5,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 123,000.00 |
| Retained Earnings | $-17.49M | $-15.66M | $-14.14M | $-92.83M | $-80.78M | $-43.85M |
| Other Shareholders Equity | -241,000.00 | 42,000.00 | 16,000.00 | 124,000.00 | 208,000.00 | N/A |
| Total Shareholders Equity | $50.61M | $-14.61M | $-13.24M | $-87.80M | $-76.78M | $-57.09M |
| Additional Paid In Capital | $68.12M | $10.37M | $9.02M | $4.91M | $3.79M | $38.13M |
| Derivative Product Liabilities | N/A | N/A | N/A | 0.00 | 0.00 | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | $3.91M |
| Inventory | N/A | N/A | N/A | N/A | N/A | $2.22M |
| Land And Improvements | N/A | N/A | N/A | N/A | N/A | 740,000.00 |
| Goodwill | N/A | N/A | N/A | N/A | N/A | $25.58M |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | $12.56M |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | $57.37M |
| Other Non Current Liabilities | N/A | N/A | N/A | N/A | N/A | 117,000.00 |